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Abstract
Background
Preterm neonatal mortality (NM) has remained high and unchanged for many years in Tanza-
nia, a resource-limited country. Major causes of mortality include birth asphyxia, respiratory
insufficiency and infections. Antenatal corticosteroids (ACS) have been shown to significantly
reduce mortality in developed countries. There is inconsistent use of ACS in Tanzania.
Objective
To determine whether implementation of a care bundle that includes ACS, maternal antibiot-
ics (MA), neonatal antibiotics (NA) and avoidance of moderate hypothermia (temperature <
36˚C) targeting infants of estimated gestational age (EGA) 28 to 34 6/7 weeks would reduce
NM (< 7 days) by 35%.
Methods
A Pre (September 2014 to May 2015) and Post (June 2015 to June 2017) Implementation
strategy was used and introduced at three University-affiliated and one District Hospital.
Dexamethasone, as the ACS, was added to the national formulary in May 2015, facilitating
its free use down to the district level.
Findings
NM was reduced 26% from 166 to 122/1000 livebirths (P = 0.005) and fresh stillbirths (FSB)
33% from 162/1000 to 111/1000 (p = 0.0002) Pre versus Post Implementation. Medications
including combinations increased significantly at all sites (p<0.0001).
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By logistic regression, combinations of ACS, maternal and NA (odds ratio (OR) 0.33),
ACS and NA (OR 0.30) versus no treatment were significantly associated with reduced NM.
NM significantly decreased per 250g birthweight increase (OR 0.59), and per one week
increase in EGA (OR 0.87). Moderate hypothermia declined pre versus post implementation
(p<0.0001) and was two-fold more common in infants who died versus survivors.
Interpretation
A low-cost care bundle, ~$6 per patient, was associated with a significant reduction in NM
and FSB rates. The former presumably by reducing respiratory morbidity with ACS and min-
imizing infections with antibiotics. If these findings can be replicated in other resource-limited
settings, the potential for further reduction of <5 year mortality rates becomes enormous.
Introduction
One-week neonatal mortality still contributes significantly to the under-5-year mortality rates
in Tanzania. [1, 2] Major contributing causes include birth asphyxia (BA), prematurity and
infection. The number of preterm infant deaths in Tanzania remains substantial at approxi-
mately 9500 annually. [2, 3] We demonstrated several years ago in a pilot study that implemen-
tation of the Helping Babies Breathe (HBB) program was associated with a significant 47%
reduction in early neonatal mortality (NM), i.e. less than 24 hours; this reduction in mortality
extended to infants less than 34 weeks gestation. [4]
Tanzania has limited capacity to continuously monitor either heart rate or respirations and/or
manage preterm infants with any respiratory distress in the newborn/preterm nursery. Specifi-
cally, the capacity to deliver continuous positive airway pressure (CPAP), to intubate and adminis-
ter surfactant as indicated, and support breathing with positive pressure ventilation is inadequate.
Moreover, antibiotics are only initiated when the preterm infant becomes symptomatic.
Given these limitations in care, we focused our attention towards a seemingly low-cost, evi-
dence-based preventative approach, which is part of standard practice in resource-replete
countries. These strategies include the administration of ACS to mothers in preterm labour,
[5, 6] maternal antibiotics when in active labour, [7, 8] immediate stabilization/resuscitation of
the newborn [9] including avoidance of moderate hypothermia (<36˚C), [10] and early neo-
natal antibiotics which we consider to be crucial first steps to reducing the burden of preterm
infant mortality. These efforts had to be partially reset following publication of a cluster ran-
domized study in low and middle-income countries comparing ACS versus standard care
administered to preterm infants of estimated gestational age (EGA) 24 to 37 weeks for the
reduction of NM. The study showed, among the whole population, that both 28-day NM and
suspected maternal infection were significantly more common in the intervention group. [11]
There were several factors that limited relevance of the findings to Tanzania and other
resource-limited countries. First, those in the intervention group were less likely to be deliv-
ered in a hospital. Second, there was a failure to address issues such as the immediate applica-
tion of HBB upon delivery, as well as the avoidance of moderate hypothermia, which has
previously been shown to have a dose-dependent relationship with mortality. [12, 13] These
were critical factors in our estimation, contributing to the “unanticipated” findings in this
report. [14] Moreover, as noted previously, all of the above interventions constitute standard
practice in resource-replete countries, and components of the package, including ACS admin-
istration, were already in use in some of the referral hospitals.
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After much national debate, the Ministry agreed to evaluate the potential benefit of the care
package which in addition included application of HBB principles and the avoidance of mod-
erate hypothermia in a pilot rollout as a precursor to potential national dissemination. The
objective of this pilot initiative was to determine whether implementation of the care package
including avoidance of moderate hypothermia to preterm infants of estimated EGA 28 to 34 6/
7 weeks, would be associated with a 35% reduction in NM 7 days.
Materials and methods
Implementation of the care package
This pilot initiative of implementing the care bundle has been supported by the Ministry of
Health and Social Welfare. Four hospitals, designated as “study sites.” included Muhimbili
National Hospital (MNH), Kilimanjaro Christian Medical Centre (KCMC), Bugando Medical
Centre (BMC) and Haydom Lutheran Hospital, were selected to evaluate the care bundle. The
process to implementation proceeded as outlined next.
National conference–prelude to development of a care bundle
A national conference was convened in Dar-es-Salaam March in 2014 and was attended by the
Ministry of Health and Social Welfare, Pediatricians, Obstetricians, and Midwives represent-
ing all regions in Tanzania, as well as Non-Government organizations including USAID, Save
the Children, UNICEF, the World Health Organization (WHO) and the Laerdal Foundation
for Acute Medicine. The care bundle that was discussed included ACS administration to
mothers of fetuses of GA 28 to 34 6/7 weeks, maternal antibiotics when in labour, implementa-
tion of HBB at delivery, avoidance of moderate hypothermia starting at delivery, and early
administration of neonatal antibiotics. Thus infants delivered following a preterm labour were
empirically treated for 48 hours if asymptomatic, and longer if there clinical signs, i.e. tachyp-
nea, retractions, etc. Exceptions included delivery secondary to maternal conditions (e.g. pre-
eclampsia). The antibiotic strategy was based on the fact that most cases of chorioamnionitis
are asymptomatic, i.e. noted on histology only. Moreover, blood cultures and inflammatory
markers are rarely obtained to evaluate for infection, and only then at the time of symptoms.
The estimated cost of the care bundle medications was $6 to $7 per mother/infant pair.
In June 2015, national guidelines for the use of ACS was prepared, followed by its addition
to the national formulary as an essential medication. This action facilitated the free use of ACS
down to the district hospital level. This strategy of making ACS freely available was consistent
with the suggestion by a Working Group for the UN Commission of Life Saving Commodities.
[15]
Development of educational tools
A 14-page educational handbook was developed that outlined the proposed interventions,
including the rational for each strategy, as well as dosing regimen for each medication. This
included Dexamethasone (6 mg intramuscularly x 4 doses every 12 hours) which was the spec-
ified ACS used, Penicillin and/or Ampicillin were the maternal antibiotics, and Ampicillin
(50 mg/kg every 12 hours) and Gentamicin (4 mg/kg every 24 hours) were administered intra-
venously to the baby. The WHO ten-step strategy for maintaining temperature was empha-
sized. [15] A flow diagram poster depicting the interventions was also developed which
supplemented the educational handout (Fig 1). The poster was placed in the delivery room
resuscitation area at each hospital.
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Importantly, the care bundle, including avoidance of moderate hypothermia, was conceived
as a bridge between labour and delivery, the first postnatal hour, and subsequent management
based on the WHO Essential Newborn Care which is practiced in almost all hospitals. [16, 17]
There was limited capacity to apply CPAP and no preterm infant was intubated.
Implementation team
HK was designated as the primary investigator of the project. A dedicated Pediatrician, Obste-
trician and Midwife was appointed at each site to facilitate implementation of the care bundle.
In general, almost all vaginal deliveries are managed by a midwife. All midwives at the study
hospitals are trained in the HBB program. A data recorder was assigned at each hospital.
Review sessions were conducted by JMP at the hospitals in August 2014, March 2015, August
2015, March 2016, August 2016 and March 2017. In addition, all team members participated
at a bi-annual data monitoring meeting in Dar-es Salaam every March and August, where
ongoing data related to the project was reviewed, implementation barriers identified and recti-
fied where possible.
Program evaluation
Data monitoring. A dedicated computer close to every labour ward was used for data
entry and subsequent transmission of data to a central repository in the Health Ministry in
Dar es Salaam. A data collection form, which included core and desired elements developed
for the HBB rollout in Tanzania, was supplemented by data points specific to the project. This
included ACS use, number of doses, maternal and neonatal antibiotic use, and initial neonatal
temperature. (Fig 2)
Each hospital started collecting Pre Implementation baseline data in September 2014 with
the implementation process initiated in June 2015. Data were analyzed by a data analyst (HK)
and technical consultant (JMP), and evaluated every six months by the study participants.
Fig 1. Flow diagram depicting the interventions to be applied in the bundle of care treatment strategy.
https://doi.org/10.1371/journal.pone.0193146.g001
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Consistency checks of the data were performed intermittently by HK and every six months by
the technical consultant at the primary sites. There were no formal stopping rules.
Definitions. Gestational age (GA) was based on self-report of the last normal menstrual
period and/or fundal height, the latter the distance from symphysis pubis to the uterine fundus
in the middle of the woman’s abdomen, as is the standard practice in Tanzania. [18] Preterm
infants of presumed EGA 28 to 34 6/7 weeks were eligible to receive the care package. Birth
weight (BW) cutoff for live births was 750 grams. Fresh stillbirth (FSB) was defined as an
Apgar score = 0 at both 1 and 5 minutes with intact skin and suspected death during labour/
delivery, and of birth weight >1000 grams.
Study Goals. The primary goal was to reduce the rate of Preterm mortality in the first 7
days after birth by 35%.
Statistical analysis. A power analysis was calculated to detect a 35% reduction in NM.
This was based on preliminary pre implementation data indicating a NM rate 7 days of 166/
1000 live births for infants < 35 weeks EGA. This indicated that approximately 545 babies pre
versus post implementation were needed with 80% power, and with use of a two-tailed test at a
significance level of 5%.
Additional subgroup analysis was undertaken to determine the potential impact of the care
bundle on infants of EGA 28 to 30 6/7 weeks and those of 31 to 34 6/7 weeks.
Analysis has been performed using Statistical Package for Social Sciences (SPSS) 22; and
included descriptive statistics, chi square analysis, t tests and relative risk (RR) calculations.
Odds ratios (OR) were calculated from the logistic regression analysis. A bivariate multiple
logistic regression was developed to estimate effects of administration of ACS, maternal and
neonatal antibiotics on predicting 7-day mortality while controlling for BW, EGA, source of
admission, delivery mode and gender. Due to the high percentage of administration of combi-
nations of ACS, maternal and neonatal antibiotics (70%) in the observed population, a new
variable with 8 scenarios of either combination of medicines or singular use versus no medica-
tions which was dummy coded and served as the reference scenario. The data was analyzed for
the entire cohort followed by subgroup analysis for preterm infants of EGA 28 to 30 6/7 weeks
and 31 to 34 6/7 weeks.
Fig 2. Data collection sheet.
https://doi.org/10.1371/journal.pone.0193146.g002
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All data are presented as mean ±standard deviation unless as otherwise stated.
Ethical considerations. Implementation of the care bundle received ethical clearance
from the National Institute of Medical Research of Tanzania. NIMR/HQ/R.8c/Vol.11/677.
Since components of the care bundle were already being clinically utilized to some extent at all
hospitals, and are considered standard practice in the resource replete settings, informed con-
sent was not sought.
Results
Between September 2014 and June 2017 there were a total of 3496 preterm infants born; 543
were pre-implementation (September 2014 to May 2015) of whom 90 (166/1000) died. During
implementation (June 2015 to June 2017) there were 2953 preterm infants born of whom 362
(122/1000) died. (Fig 3) This reflects a 26% reduction, i.e. RR 0.74 (95% confidence interval
(CI) 0.60–0.91) (p = 0.005) pre vs post implementation. (Fig 3). There were 105 FSB (162/
1000) pre and 369 (111/1000) post implementation which represents a 33% reduction, i.e. RR
0.67 (CI 0.54–0.82) (p = 0.0002).
The impact of implementation of the care bundle on death and fresh stillbirth rates for the
four hospitals is shown in Table 1. Note the significant reduction in NM at MNH, RR 0.58
(0.42–0.81) (p = 0.0001) only, as well as a reduction in FSB rates RR 0.46 (0.36–0.59)
(p<0.0001). At BMC there was a significant reduction in FSB rates 0.26 (0.12–0.0.58)
(p = 0.0009). There were no differences in NM or FSB rates at the other hospitals.
General characteristics and medication use pre versus post implementation
Infants were of comparable BW (p = 0.10) but lesser GA (p<0.0001) pre versus post imple-
mentation (Table 2). There were no differences related to gender and mode of delivery. How-
ever, there were more referrals post implementation (p = 0.0001) (Table 2). The use of
maternal antibiotics, ACS, neonatal antibiotics and a combination of medication increased
with implementation (p<0.0001 for all). (Table 2). Temperature measurements increased
more than three-fold pre versus post implementation (p<0.0001). The number of infants with
moderate hypothermia decreased two-fold pre versus post implementation (p<0.0001). Con-
versely the number of infant with a temperature in the normal range increased more than
three-fold pre versus post implementation (p<0.0001). (Table 2)
Fig 3. Outcomes pre and post implementation.
https://doi.org/10.1371/journal.pone.0193146.g003
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The general characteristics and medication use at the four hospitals pre
versus post implementation (Table 3)
There were differences in BW and GA at MNH (lower) (p< 0.0001), BW at KCMC (greater)
(p = 0.01) and BW at Haydom (lower) (p< 0.0001) pre versus post implementation. There
Table 1. Neonatal mortality and fresh stillbirths at the four hospitals, pre and post bundle of care implementation.
Hospital Neonatal Mortality Fresh Still Births
Pre-Implementation Post-
Implementation
RR,
95% CI,
P-Value
Pre-Implementation Post-
Implementation
RR,
95% CI,
P-Value
MNH 33/159
(20.7%)
271/2222
(12.2%)
0.58
(0.42–0.81)
P = 0.001
58/217
(26.7%)
311/2533 (12.3%) 0.46
(0.36–0.59)
P<0.0001
KCMC 27/205
(13.1%)
54/388
(13.9%)
1.05
(0.68–1.62)
P = 0.80
20/205
(9.7%)
43/431
(9.9%)
1.12
(0.67–1.86)
P = 0.65
BMC 18/118
(15.2%)
27/261
(10.3%)
0.67
(0.38–1.18)
P = 0.17
17/135
(12.6%)
9/270
(3.3%)
0.26
(0.12–0.58)
P = 0.0009
Haydom 12/61
(19.7%)
10/82
(12.2%)
0.61
(0.28–1.34)
P = 0.22
10/71
(14.1%)
6/88
(6.8%)
0.48
(0.12–1.26)
P = 0.13
Totals 90/543
(16.6%)
362/2953
(12.2%)
0.74
(0.60–0.91)
P = 0.005
105/648
(16.2%)
369/3322
(11.1%)
0.67
(0.54–0.82)
P = 0.0002
MNH = Muhimbili National Hospital, KCMC = Kilimanjaro Christian Medical Centre, BMC = Bugando Medical Center. RR = Relative Risk, CI = Confidence Interval
https://doi.org/10.1371/journal.pone.0193146.t001
Table 2. General characteristics of infants before and after implementation.
Category Pre-Implementation
n = 543
Post-
Implementation
n = 2953
P-Value
Birth Weight (Grams) 1684 ± 420 1716 ± 424 0.10
Gestational Age (Weeks) 31.17 ± 2.0 31.66 ± 1.99 < 0.0001
Inborn/Referral 320/212 1156/1538 < 0.0001
Gender (Male/Female) 261/282 1453/1495 0.60
Mode of Delivery
(Vaginal/C-Section/Vacuum)
279/244/17 1350/1379/218 0.10
Maternal Antibiotics 167 (30.8%) 2071 (70.1%) < 0.0001
Antenatal Corticosteroids 185 (34%) 2064 (69.9%) < 0.0001
Neonatal Antibiotics 152 (28%) 2395 (81.1%) < 0.0001
ACS + Maternal + Neonatal Antibiotics 152 (28%) 1712 (58%) < 0.0001
Temperature Measurements 152 (28%) 2395 (82%) < 0.0001
Moderate (33.0–35.9˚C)
Mild (36.0–36.4˚C)
Normal (36.5–37.5˚C)
42 (27.6%)
86 (56.6%)
24 (15.8%)
317 (13.3%)
825 (34.6%)
1243 (52.1%)
< 0.0001
ACS = Antenatal Corticoid Steroids
Birthweight missing value n = 7. Gender missing values n = 5, Inborn/Referral missing values (n = 270) Mode of delivery missing values n = 9
Infants 750-1000g Pre versus Implementation n = 25 (4.6%) vs n = 95 (3.2%), p = 0.10.
Infants <28 weeks gestational age Pre vs Implementation n = 7 (1.2%) versus n = 8 (0.27%) p = 0.0007. Data analyzed with Students t test and Person Chi Square
analysis.
https://doi.org/10.1371/journal.pone.0193146.t002
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were differences in GA at KCMC, BMC and Haydom. There were less referrals post imple-
mentation at BMC (p = 0.0002) and more males versus females at Haydom (p = 0.0007) post
implementation. There were no differences in mode of delivery at any site. All medication
increased significantly at all sites, except at KCMC where there were no differences in ACS use
pre versus during implementation, i.e. 53.7 vs 57% (p = 0.40).
Characteristics of infants who died versus infants who survived (Table 4)
Infants who died versus those who survived were of a lesser BW and GA (p<0.0001 for both),
were more likely to be referred (p< 0.0001), and delivered by a vacuum extraction (p = 0.007).
There were no differences related to sex. The administration of maternal antibiotics (p = 0.01),
ACS, neonatal antibiotics and a combination of ACS, maternal and neonatal antibiotics were
all less in those who died versus survivors (p<0.0001 for all). Infants who died versus survivors
were two-fold more likely to present with moderate hypothermia (p<0.0001) and less likely to
have a temperature in the normal range (p = 0.003). (Table 4)
Impact of ACS dosing on NM rates
There was a dose dependent effect of ACS on NM for the entire cohort (Table 5). Comparing
no ACS exposure versus a full course (3/4 doses), there was a significant reduction in NM
from 18.9% (no ACS) to 7.6% (3/4 doses) (RR 0.48 (CI 0.37–0.61), p<0.0001. Comparing no
Table 3. General characteristics and medication use at the four hospitals pre/post implementation.
Muhimbili National Hosp. KCMC Bugando Haydom
Pre-I Post-I P Value Pre-I Post-I P Value Pre-I Post-I P Value Pre-I Post-I P Value
159 2222 205 388 118 261 61 75
Birthweight
(Grams)
1541 ±
322
1711 ± 416 <0.0001 1853 ± 484 1756 ± 457 0.016 1621 ± 339 1601 ± 334 0.59 1736 ± 373 1989 ± 31.6 <0.0001
Gestational Age
(Weeks)
31.1 ±
2.1
31.9 ± 1.9 <0.0001 31.6 ± 2.1 31.69 ± 2 0.60 30.3 ± 1.36 30.28 ± 1.60 0.90 31.8 ± 1.9 31.6 ± 2.0 0.55
Inborn/
Referred
53/
106
784/
1296
0.30 102/
103
180/
208
0.43 114/
4
158/
29
0.0002 50/
11
60/
15
0.77
Mode of
Delivery
Vaginal 68 995 0.49 101 165 0.21 64 137 0.91 46 53 0.35
C-Section 80 1037 97 200 52 117 15 25
Vacuum 8 184 7 23 2 7 0 4
Gender
Male/
Female
73/
86
1048/
1170
0.74 102/
103
222/
166
0.08 60/
58
130/
131
0.85 26/
35
53/
22
0.002
Medications
Maternal
Antibiotics
42
(26.4%)
1674
(75.3%)
<0.0001 104
(50.7%)
295 (76%) <0.0001 14 (11.9%) 78 (29.9%) <0.0001 7 (11.5%) 24 (29%) 0.01
ACS 28
(17.6%)
1629
(73.3%)
<0.0001 110
(53.7%)
222 (57%) 0.40 45 (38.1%) 195 (74.7%) <0.0001 2
(3.3%)
18 (22%) <0.0001
Neonatal Antibiotics 2
(1.3%)
1892
(85.1%)
<0.0001 107 (52%) 298
(76.8%)
<0.0001 32 (27.1%) 181 (69%) <0.0001 18 (29.5%) 51
(62%)
0.0001
Temperature
Measured
0 1780 (80%) 81
(39.5%)
297
(76.5%)
<0.0001 58
(49%)
258 (99%) <0.0001 13
(21.3%)
50 (61%) <0.0001
I = Implementation, C-Section = Cesarean section, ACS = Antenatal Corticosteroids. KCMC = Kilimanjaro Christian Medical Center.Data were analyzed with Pearson
Chi Square and student t tests where appropriate.
https://doi.org/10.1371/journal.pone.0193146.t003
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ACS exposure versus a partial course (1/2 doses), there was a significant reduction in NM
from 18.9% (no ACS) to 12.6% (partial course) (RR 0.66 (CI .0.54–0.81) (p = 0.0001). Compar-
ing partial versus a complete course there is a significant reduction in NM from 12.6% (partial)
to 7.6% (complete course) (RR 0.60 (CI 0.47–0.78 (p = 0.0001).
Stepwise logistic regression analysis
Stepwise logistic modelling included BW in increments of 250 grams, GA in increments of
one week, inborn versus referral, mode of delivery, sex and medications either singularly or in
combination. Initial temperature was not included as a predictor due to 27.1% of missing
values.
Significant predictors of a reduction in NM were combination therapy, i.e. ACS and neona-
tal antibiotics (OR 0.303, p = 0.0001) and ACS, maternal and neonatal antibiotics (OR 0.332,
p = 0.0001), inborn cases (OR 0.57, p = 0.0001), increased BW (OR 0.593) and GA (OR 0.877,
Table 4. General characteristics of infants<35 weeks who survived versus died.
Survived
n = 3044
Death
n = 452
p
Birthweight (grams) 1761 ± 398 1379 ± 409 < 0.0001
Gestational Age (weeks) 31.98 ± 1.9 30.6 ± 2.1 < 0.0001
Source of Admission–Inborn 1330 (47%) 146 (35%) < 0.0001
Gender: Male 1493 (49.1%) 221 (49%) 0.965
Mode of Delivery
Vaginal 1409(46.4%) 220 (48.7%) 0.66
Cesarean Section 1430 (47.1%) 193 (42.7%) 0.27
Vacuum 196 (6.5%) 39 (8.6%) 0.007
Maternal Antibiotics given 1987 (65.3%) 251 (55.5%) 0.01
Antenatal Corticosteroids given 2033 (66.8%) 216(47.8%) < 0.0001
Neonatal Antibiotics given 2236 (76.7%) 245 (52.8%) < 0.00001
Antenatal Corticosteroids and Maternal and Neonatal Antibiotics 1577 (51.8%) 133 (29.4%) < 0.0001
Temperature measurement 2248 (73.7%) 299 (66.2%) 0.0001
Hypothermia:
Moderate 33.0–35.9˚C
Mild 36.0–36.4˚C
Normal 36.5–37.5˚C
282 (12.6%)
813 (36.3%)
1144 (51.1%)
77 (25.8%)
98 (32.9%)
123 (41.3%)
< 0.0001
0.25
0.003
Birthweight  Missing Values n = 7
Temperature measurements missing Pre-implementation n = 796, Post-implementation n = 153 (p<0.0001).
Data were analyzed with Pearson Chi Square and student t tests where appropriate.
https://doi.org/10.1371/journal.pone.0193146.t004
Table 5. Outcome of preterm infants expected to 1/2 (partial) or 3/4 (complete) doses of dexamethasone versus
no treatment.
No Doses 1/2 Doses 3/4 Doses
Survived 817# 1030 1059
Died 191 (18.9%) 149 (12.6%) 88 (7.6%)
Total 1008 1179 1147
Missing doses n = 162
 Difference in outcome for infants who died (none vs 3/4 doses) p<0.0001
# Difference in outcome for infants who died (none vs 1/2 doses) p = 0.0001
 Difference in outcome for infants (1/2 doses vs 3/4 doses) p = 0.0001
https://doi.org/10.1371/journal.pone.0193146.t005
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both p = 0.0001). Predictors associated with increased NM risk, included ACS and maternal
antibiotics (OR 2.825, p = 0.0001) and ACS only (OR 1.796, p = 0.071). (Table 6)
Impact of the care bundle on preterm infants of EGA 28 to 30 6/7 weeks
and 31 to 34 6/7 weeks (Table 7)
NM for infants 28 to 30 6/7 weeks was 45/230 (19.6%) versus 198/884 (22.4%), (RR 1.14 (CI
0.85–1.52) (p = 0.35), and for infants 31 to 34 6/7 weeks 45/313 (14.4%) versus 164/2069
Table 6. Stepwise logistic regression Analysis for estimating effects of administration of antenatal corticosteroids (ACS), maternal & neonatal antibiotics in combi-
nation or singularly for predicting death in preterm infants while controlling for BW, GA, source of admission, mode of delivery and gender.
B SE Sig Exp(B) 95% CI for Exp(B)
Lower Upper
Step 3 BW per 250 g -0.523 0.042 0.0001 0.593 0.546 0.643
Gestational Age per week -0.131 0.031 0.0001 0.877 0.825 0.933
Inborn 0.562 0.125 0.0001 0.570 0.446 0.729
ACS+ Maternal+ Neonatal Antibiotics -1.103 0.154 0.0001 0.332 0.245 0.449
ACS + Neonatal Antibiotics -1.194 0.234 0.001 0.303 0.192 0.479
ACS +Maternal Antibiotics 1.050 0.326 0.001 2.825 1.507 5.414
ACS only 0.586 0.324 0.071 1.796 0.952 3.399
Maternal and Neonatal Antibiotics -0.309 0.232 0.182 0.734 0.466 1.156
Maternal Antibiotics -0.016 0.225 0.932 0.984 0.633 1.530
Neonatal Antibiotics -0.246 0.262 0.346 0.782 0.468 1.305
Constant 4.945 0.920 0.0001 140.491
BW = Birth weight, GA = Gestational Age, ACS = Antenatal Corticosteroids
Infants with missing values (n = 288) for predictors were excluded. Initial temperature was not included as a predictor due to 27.1% of missing values.
https://doi.org/10.1371/journal.pone.0193146.t006
Table 7. General characteristics of Infants 28–30 6/7 weeks vs. 31–34 6/7 weeks who survived versus died.
28–30 6/7 Weeks
n = 1114
31–34 6/7 Weeks
n = 2382
Survived
n = 871
Died
n = 243
p Survived
n = 2173
Died
n = 209
p
Birthweight (grams)1 1558 ± 406 1242 ± 366 < 0.00001 1842 ± 372 1540 ± 390 < 0.00001
Gestational Age (weeks) 29.25 ± 0.88 28.87 ± 1.09 < 0.00001 32.86 ± 1.04 32.48 ± 1.047 < 0.0001
Inborn2 463 (57.4%) 81 (37.3%) < 0.00001 867 (43.2%) 65 (33.7%) 0.01
Gender: Male3 433 (49.7%) 122 (50.2%) 0.89 1060 (51.1%) 109 (52.4%) 0.72
Maternal Antibiotics given 475 (54.5%) 126 (51.9%) 0.45 1512 (69.6%) 125 (59.8%) 0.003
ACS 547 (62.8%) 119 (49%) 0.0001 1486 (68.4%) 97 (46.4%) < 0.0000
Neonatal Antibiotics given 603 (69.2%) 129 (53.1%) < 0.00001 1733 (79.8%) 116 (55.5%) < 0.0000
ANS and Maternal and Neonatal Antibiotics 371 (42.6%) 75 (30.9%) 0.003 1206 (55.5%) 58 (27.8%) = 0.0001
Temperature measurement4 612 (70.2%) 159 (65.4%) 0.15 1627 (74.8%) 139 (66.5%) 0.003
Hypothermia:
Moderate 33.0–35.9˚C
Mild 36.0–36.4˚C
Normal 36.5–37.5˚C
88 (14.4%)
241 (39.4%)
283 (46.2%)
39 (24.5%)
51 (32.1%)
69 (43.4%)
0.002
0.09
0.52
194 (11.9%)
572 (35.2%)
861 (52.9%)
38 (27.3%)
47 (33.8%)
54 (38.8%)
0.0001
0.74
0.001
ACS = Antenatal corticosteroids. Data were analyzed with Pearson Chi Square and Student t tests where appropriate.
Birthweight1 missing values n = 7
Inborn2 missing values n = 270
Gender3 missing values n = 5
Temperature4 measurements missing values n = 949 (27.1%) Temperature categories excluded n = 10 that had temperature >37.5˚C
https://doi.org/10.1371/journal.pone.0193146.t007
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(7.9%) RR 0.55 (CI 0.40–0.75) (p = 0.0001) pre versus post implementation respectively. The
subgroup analysis for infants who survived versus those who died was similar to the overall
cohort of infants. (Table 7). Specifically infants who died versus those who survived were of a
lesser BW and GA for both subgroups (p<0.0001 for both), were more likely to be referred for
both subgroups i.e. infants 28–30 6/7 weeks (p< 0.0001) and 31 to 34 6/7 weeks (p = 0.01).
There were no differences related to sex. The administration of maternal antibiotics was not
different for infants 28 to 30 6/7 weeks (p = 0.45), but infants 31 to 34 6/7 weeks who survived
were more likely to receive maternal antibiotics (p = 0.003). Administration of ACS only, neo-
natal antibiotics only, and a combination of ACS, maternal and neonatal antibiotics were all
less in those who died versus survivors (p<0.0001) for both subgroups. Moderate hypothermia
was 1.5 fold more likely in infants of 28 to 30 6/7 weeks (p = 0.002), and 2.5 fold more likely in
infants 31 to 34 6/7 weeks (p = 0.0001) who died versus those who survived.
Stepwise logistic regression analysis for infants 28 to 30 weeks and 31 to 34
6/7 weeks EGA (Tables 8 and 9)
Stepwise logistic modelling for both subgroups was similar to the overall cohort. Significant
predictors of a reduction in NM were combination therapy, i.e. ACS and neonatal antibiotics,
Table 8. Stepwise logistic regression analysis for estimating effects of administration of antenatal corticosteroids (ACS), maternal & neonatal antibiotics in combi-
nation or singularly for predicting death in p[reterm infants while controlling for BW, GA, source of admission, mode of delivery and gender for infants 28 to 30 6/
7 weeks GA.
B SE Sig Exp(B) 95% CI for Exp(B)
Lower Upper
BW per 250 g -0.515 0.063 0.0001 0.597 0.528 0.675
Gestational Age per week -0.115 0.089 0.197 0.892 0.749 1.061
Inborn -0.797 0.177 0.0001 0.451 0.319 0.638
ACS+ Maternal+ Neonatal Antibiotics -0.923 0.215 0.0001 0.397 0.261 0.606
ACS + Neonatal Antibiotics -1.372 0.336 0.001 0.253 0.131 0.490
ACS +Maternal Antibiotics 0.610 0.483 0.206 1.84 0.715 4.72
ACS only 0.181 0.447 0.686 1.198 0.499 2.876
Constant 4.997 2.496 0.045 148.004
BW = Birth weight, GA = Gestational Age ACS = Antenatal Corticosteroids
Infants with missing values (n = 288) for predictors were excluded. Initial temperature was not included as a predictor due to 27.1% of missing values.
https://doi.org/10.1371/journal.pone.0193146.t008
Table 9. Stepwise logistic regression analysis for estimating effects of administration of antenatal corticosteroids (ACS), maternal & neonatal antibiotics in combi-
nation or singularly for predicting death in preterm infants while controlling for BW, GA, source of admission, mode of delivery and gender for infants 31 to 346/7
weeks.
B SE Sig Exp(B) 95% CI for Exp(B)
Lower Upper
BW per 250 g -0.527 0.057 0.0001 0.590 0.528 0.660
Gestational Age per week -0.268 0.078 0.001 0.765 0.657 0.891
Inborn -0.295 0.177 0.095 0.745 0.527 1.053
ACS+ Maternal+ Neonatal Antibiotics -1.267 0.227 0.0001 0.282 0.181 0.439
ACS + Neonatal Antibiotics -0.957 0.327 0.003 0.384 0.202 0.728
ACS +Maternal Antibiotics 1.468 0.466 0.011 3.25 1.305 8.102
ACS only 1.179 0.324 0.071 1.796 0.952 3.399
Constant 9.76 2.49 0.0001 17332.5
BW = Birth weight, GA = Gestational Age ACS = Antenatal Corticosteroids
https://doi.org/10.1371/journal.pone.0193146.t009
Care bundle including antenatal corticosteroids reduces premature infant death in Tanzania
PLOS ONE | https://doi.org/10.1371/journal.pone.0193146 March 7, 2018 11 / 16
i.e. for infants 28 to 30 6/7 weeks (OR 0.253, p = 0.001) and infants 31 to 34 6/7 weeks (OR
0.384, p = 0.003) as well as for combined ACS, maternal and neonatal antibiotics, i.e. for
infants 28 to 30 6/7 weeks (OR 0.397, p = 0.0001) and for infants 31 to 34 6/7 weeks (OR 0.282,
p = 0.0001). Additional predictors of reduced NM included inborn cases for 28 to 30 6/7
weeks only (OR 0.45, p = 0.0001), increased BW (OR 0.59) (p = 0.0001) for both groups and
GA (OR 0.765) (p = 0.001) for infants 31 to 34 6/7 weeks only. Predictors associated with
increased NM risk, included ACS and maternal antibiotics (OR 3.25, p = 0.01) and ACS only
(OR 1.79, p = 0.071) in infants of GA 31 to 34 6/7 weeks. (Table 9)
Compliance with the implementation plan
There was a significant increase in use of all medications over time. The only exception was for
ACS use at KCMC, where there was no difference pre versus post implementation. By June
2017, Neonatal Antibiotics had increased to 90%, ACS to 84%, Maternal Antibiotics to 66%
and a combination of medications to 58%. Over the corresponding time frame, moderate
hypothermia declined three-fold from 27% to 9.3%. (Fig 4)
Fig 4. Use of medication either singularly or in combination from September 2014 through June 2017. NM
progressively decreased over the comparable time period concurrent with the increased use of medication. (Fig 5).
https://doi.org/10.1371/journal.pone.0193146.g004
Fig 5. The progressive decrease in mortality from September 2014 through June 2017. Comparing years 2014 and
2017—Relative Risk Reduction (RR) and 95% Confidence Interval (CI) 0.658 (0.45–0.96) p = 0.031,  Comparing
years 2015–2017—RR 0.84 (0.73–0.97) p = 0.016.  Comparing 2016 and 2017 RR 0.91 (0.78–1.06) p = 0.22.
https://doi.org/10.1371/journal.pone.0193146.g005
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Fresh stillbirths
FSB pre (n = 105) (162/1000) versus post implementation (n = 369) (111/1000) were of compa-
rable BW, 1486±421 grams versus 1520± 438 grams (p = 0.51) but of lesser GA, 30.44 ± 2.0
weeks vs 30.97 ±2.1 weeks (p = 0.03). There were no differences with regard to source of
admission, gender and mode of delivery.
Discussion
The principal finding of this pilot implementation initiative incorporating a care-package
strategy, was significant for an overall 26% reduction in NM 7 days, and an unanticipated
33% reduction in FSB rates in preterm infants 28 to 34 6/7 weeks EGA. By subgroup analysis
there was no difference in NM for infants 28 to 30 6/7 weeks EGA, but a significant 45% reduc-
tion for infants of EGA 31 to 34 6/7 weeks following implementation. Neonatal characteristics
associated with increased NM included lesser BW, lower GA and outborn deliveries, particu-
larly in preterm infant 28 to 31 6/7 weeks. Interventions associated with reduced NM included
the combined use of ACS and neonatal antibiotics (70%) ± maternal antibiotics (67%). ACS
when used alone was associated with a non-significant increase in NM, and a combination of
ACS and maternal antibiotics was associated with an increased risk of NM, an effect that was
most pronounced in the larger preterm infant> 30 6/7 weeks GA. Infants who died had lower
initial temperatures as compared to survivors. There was a progressive decrease in NM per
year of implementation, which corresponded to an increase in medication use as well as a
decrease in moderate hypothermia.
Implementation of the care bundle was uneven. Thus the use of ACS increased substantially
at three hospitals. Although the increase in use was significant at Haydom, only 22% of moth-
ers received ACS post implementation. This low percentage appears to be related to the fact
that many mothers arrive at this hospital already in well-established labour. At KCMC there
was no difference in ACS administration pre versus post implementation. We consider this
the most plausible explanation for the apparent lack of effect of the care bundle on NM at this
hospital. Given that many mothers may arrive in labour late, the ACS administration rate of
approximately 68% (range 57 to 74%) at MNH, KCMC and BMC would seem to be an achiev-
able goal at most hospitals. Regarding other components of the care bundle, maternal antibiot-
ics increased substantially at all hospitals, although the rate was approximately 30% at BMC
and Haydom. A potential explanation for the lower administration at BMC may reflect a
maternal fee for antibiotic use at this hospital. A marked increase in use of neonatal antibiotics
was noted at all hospitals. Finally, combination therapy increased more than two fold to 58%
post implementation. This is relevant since combination therapy that included ACS and anti-
biotics was associated with a marked reduction in NM (range 67 to 70%). Temperature mea-
surements increased significantly at all sites. Focus on maintaining temperature was
accompanied by a three-fold reduction in moderate hypothermia post implementation.
These pilot observations are important and consistent with proof of concept, that interven-
tions which are standard practice in developed countries, if implemented in a resource-limited
setting, can significantly reduce NM. This is highly relevant for Tanzania and other resource
limited countries, with minimal respiratory support other than oxygen supplementation, and
the inability to routinely undertake a basic infectious workup. However, successful implemen-
tation is a complex issue influenced by many factor including BW, GA, temperature, delivery
location, and adherence to the care bundle. The impact on NM was extremely favourable with
combination therapy involving ACS and neonatal antibiotics ± maternal antibiotics. Con-
versely and surprisingly, a combination of ACS and maternal antibiotics was associated with
increased mortality, an effect that was particularly prominent in the larger preterm infant 31 to
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34 6/7 weeks GA. Potential factors contributing to this unanticipated observation remain
unclear but important to elucidate. Both maternal and neonatal antibiotics when used singu-
larly had no impact on NM. We speculate the benefit of combination therapy (ACS and antibi-
otics) on NM relates in part to the well-described positive impact on lung development and
enhancement of pulmonary function with ACS. However, the pre-emptive approach to treat-
ing possible neonatal infection is likely an important contributing factor.
The administration of ACS to mothers of expectant preterm infants has long been the stan-
dard of care in the resource-replete setting and has consistently been associated with a reduc-
tion in NM in the preterm infant.[19] In the most recent Cochrane review, administration of
ACS to mothers of preterm infants was associated with a significant reduction in NM and
major morbidities, i.e. moderate/severe respiratory distress syndrome.[20] The authors con-
cluded, “most evidence comes from high income countries and hospital settings; therefore,
the results may not be applicable to low-resource settings with high rates of infections.” The
data in this report support this hypothesis. Thus when used alone, ACS was associated with
increased NM, consistent with the findings of Althabe, et al. [11] However, when ACS was
combined with antibiotics there was a significant reduction in NM. Moreover there was a dose
dependent positive effect of ANS on reducing NM. We consider these factors as the most likely
explanation accounting for the differences in outcome between the Althabe and our study.
[11, 14]
The necessity to avoid moderate hypothermia is a desired goal given that there is strong evi-
dence of a dose dependent increase in mortality. [12,13] In this report, moderate hypothermia
was almost two fold more likely to be present in those infants who died. Conversely, the find-
ing that survivors were more likely to have temperatures in the normal range, may in part
reflect the overall positive impact of ACS, including through an enhanced skin barrier. [21]
The care bundle preventative strategy was introduced with the goal of serving as a bridge
linking labour and delivery (maternal antibiotics and ACS), resuscitation (HBB and thermal
protection), the “Golden Hour” following delivery (continued thermal protection and early
initiation of antibiotics), with the subsequent practice of providing essential newborn care
(breast-feeding, eye-care, and continued management of infections). The “Golden Hour” is an
increasing important concept in the resource-replete setting for improving extremely Preterm
infant outcomes. [22]
The reasons contributing to the unanticipated reduction in FSB rates remain unclear. We
speculate this may reflect an in utero effect of ACS on lung development. This in turn may
have facilitated spontaneous respirations upon delivery, or in response to stimulation and suc-
tioning in the non-breathing infant. However, FSB were of a lesser GA but comparable BW
when comparing the pre- versus the post-implementation period. This observation will be
important to trend as the rollout of the care bundle moves forth in Tanzania.
The study has several limitations. First, it was not randomized but rather a pilot implemen-
tation initiative. We chose this approach because we considered it unethical to perform a ran-
domized study, given the overwhelming evidence, for a reduction in neonatal and major
morbidities with ACS and antibiotics.[20] Second, the data collection form specifically devel-
oped for the care bundle, only became a mandatory part of record in September 2014. This
limited the pre-implementation period for data collection. In this regard as noted previously,
at KCMC approximately 50% of the mothers had received ACS during the pre-implementa-
tion period. Third, we were unable to determine the overall contribution of intrauterine
growth restriction to the findings in this preterm population, in part because of a lack of rele-
vant information in the data collection form. Fourth, since this was an evaluation of routine
practice change and audit of outcomes, there is a chance that other (unrecorded) care practices
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also changed purely by coincidence. This could have introduced some potential for bias in the
measurement of effect size.
In conclusion, a low cost care bundle and adherence to temperature control, relatively easy
to administer by an obstetric provider, was associated with a significant reduction in preterm
mortality, presumably by reducing respiratory morbidity and minimizing infection. If the
findings can be replicated in other resource-limited settings, the ability to further reduce the
less than 5 year mortality rates is enormous.
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